Salmonella Species
% Resistance to Antibiotics by Main Serotype
(Disk Diffusion, CLSI Recommendations)
(January-December 2013)
S. Enteritidis (No tested 67) |
S. Typhimurium (No tested 58) |
S. monophasic Typhimurium (No tested 45) |
All other serotypes (No tested 141) |
|||||||
Antibiotic name | %R |
Antibiotic name | %R |
Antibiotic name | %R |
Antibiotic name | %R |
|||
Ampicillin | 4,5% |
Ampicillin | 19,0% |
Ampicillin | 62,2% |
Ampicillin | 6,4% |
|||
Amoxicillin/Clavulanic acid | 0,0% |
Amoxicillin/Clavulanic acid | 3,4% |
Amoxicillin/Clavulanic acid | 0,0% |
Amoxicillin/Clavulanic acid | 0,7% |
|||
Cefotaxime | 0,0% |
Cefotaxime | 1,7% |
Cefotaxime | 0,0% |
Cefotaxime | 2,2% |
|||
Ceftazidime | 0,0% |
Ceftazidime | 1,7% |
Ceftazidime | 0,0% |
Ceftazidime | 1,4% |
|||
Amikacin | 0,0% |
Amikacin | 0,0% |
Amikacin | 0,0% |
Amikacin | 1,4% |
|||
Kanamycin | 0,0% |
Kanamycin | 1,7% |
Kanamycin | 2,3% |
Kanamycin | 3,6% |
|||
Tobramycin | 0,0% |
Tobramycin | 3,4% |
Tobramycin | 2,2% |
Tobramycin | 1,4% |
|||
Netilmicin | 0,0% |
Netilmicin | 0,0% |
Netilmicin | 0,0% |
Netilmicin | 1,4% |
|||
Spectinomycin | 4,5% |
Spectinomycin | 10,3% |
Spectinomycin | 15,6% |
Spectinomycin | 4,3% |
|||
Streptomycin | 3,0% |
Streptomycin | 20,7% |
Streptomycin | 57,8% |
Streptomycin | 9,9% |
|||
Trimethoprim | 3,0% |
Trimethoprim | 8,6% |
Trimethoprim | 17,8% |
Trimethoprim | 5,0% |
|||
Sulfonamides | 0,0% |
Sulfonamides | 16,3% |
Sulfonamides | 30,3% |
Sulfonamides | 7,4% |
|||
Tetracycline | 3,0% |
Tetracycline | 36,2% |
Tetracycline | 82,2% |
Tetracycline | 7,1% |
|||
Chloramphenicol | 1,5% |
Chloramphenicol | 5,2% |
Chloramphenicol | 6,7% |
Chloramphenicol | 2,8% |
|||
Nalidixic acid | 4,5% |
Nalidixic acid | 1,7% |
Nalidixic acid | 0,0% |
Nalidixic acid | 5,0% |
|||
Ciprofloxacin | 0,0% |
Ciprofloxacin | 0,0% |
Ciprofloxacin | 0,0% |
Ciprofloxacin | 0,0% |